A Phase III, Open-label, Prospective, Multicenter Study to Assess Efficacy, Safety of Kedrion
Clinical Trial Grant
Administered By
Pediatrics, Allergy and Immunology
Awarded By
Kedrion S.p.A.
Start Date
October 10, 2025
End Date
April 5, 2027
Administered By
Pediatrics, Allergy and Immunology
Awarded By
Kedrion S.p.A.
Start Date
October 10, 2025
End Date
April 5, 2027